TAM
DVAX

Tiverton Asset Management’s Dynavax Technologies DVAX Stock Holding History

Tiverton Asset Management’s Portfolio DVAX Stock Details DVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-12,080
Closed -$150K – 499
2018
Q3 		$150K Hold
12,080
– – 0.01% 344
2018
Q2 		$184K Buy
+12,080
New +$209K 0.01% 325

Other funds holding DVAX

HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return

Tiverton Asset Management's DVAX Position: Q4 2018 in Review

Tiverton Asset Management sold out of Dynavax Technologies (DVAX) in Q4 2018, closing a stake of 12,080 shares — an estimated $150K sold.

Tiverton Asset Management first reported a position in DVAX in Q2 2018 and held it in 2 quarters. The position peaked at $184K in Q2 2018. 132 funds tracked by Wall St. Rank hold DVAX as of Q4 2018.

  • Tiverton Asset Management reported no remaining Dynavax Technologies position as of Q4 2018 after selling out during the quarter.
  • Tiverton Asset Management sold 12,080 Dynavax Technologies shares in Q4 2018, an estimated $150K.
  • Tiverton Asset Management first reported a position in Dynavax Technologies in Q2 2018 and held it in 2 quarters.
  • Tiverton Asset Management's Dynavax Technologies position peaked at $184K in Q2 2018.
  • 132 funds tracked by Wall St. Rank held Dynavax Technologies as of Q4 2018.

Based on Tiverton Asset Management's 13F filing for Q4 2018, filed 13 Feb 2019.